Pick a Topic:
Find info on a:
ClotCare complies with the HONcode standard for trustworthy health
information:
verify here.
ClotCare is a member organization of the Coalition to Prevent Deep Vein Thrombosis. Click here to learn more about the Coalition to Prevent Deep Vein Thrombosis and DVT Awareness Month, which is held each March.
|
Postings on Acute Coronary Event Prophylaxis
|
Postings for Healthcare Providers
|
Date Posted
|
|
Should We Stop Using Aspirin to Prevent a First Heart Attack or Stroke?
|
December 2018
|
|
Should We Stop Using Aspirin to Prevent a First Heart Attack or Stroke?
|
December 2018
|
|
A Contrarian’s View on the 2018 Chest Guideline for Antithrombotic Therapy in Atrial Fibrillation
|
November 2018
|
|
Is it Time to Tailor the Dose of Aspirin for Primary Prevention of Cardiovascular Events and Cancer? [Or…Why I changed my aspirin dosing schedule]
|
August 2018
|
|
Rivaroxaban or Warfarin in Stable Coronary Artery Disease – Should the COMPASS Study Lead Us Back to the Future?
|
September 2017
|
|
A Summary and Update on Combining Antiplatelet Agents and/or Oral Anticoagulants
|
February 2014
|
|
Stable Ischemic Heart Disease (SIHD) Guidelines Published
|
June 2013
|
|
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
|
January 2013
|
|
Unstable Angina/Non-ST-Elevation Myocardial Infarction: Updated Guideline
|
July 2012
|
|
New Chest Guidelines Available Now
|
February 2012
|
|
Clopidogrel and PPI use Consensus Report from the ACC Foundation, the ACG
|
December 2010
|
|
SPIRIT IV: Everolimus (XIENCE V®) drug eluting stent (DES) may be superio
|
November 2010
|
|
FDA approves Pradaxa (dabigatran) to prevent stroke in people with atrial
|
October 2010
|
|
FDA Recommends Dabigatran Approval: Agree with no ASA, still skeptical on
|
October 2010
|
|
Medication Errors in Cardiovascular & Stroke Patients
|
June 2010
|
|
Study Finds Re-hospitalization for MI Increased Two-fold with PPI and Clo
|
June 2010
|
|
Plavix & Prilosec Interaction: An FDA Alert & Questions Regarding Clinica
|
March 2010
|
|
Expert Presentations on Atherothrombosis and Plaque Rupture, Pulmonary Em
|
August 2009
|
|
FDA Approves Effient (prasugrel) to Reduce the Risk of Heart Attack in An
|
July 2009
|
|
Reduction in cardiovascular events with Rosuvastatin correlates with hsCR
|
June 2009
|
|
Aspirin for Primary Prevention of Strokes and Heart Attacks
|
April 2009
|
|
Clopidogrel Resistance: Effect on Outcomes, Genetic Causes, How to Test f
|
December 2008
|
|
Heart attack and stroke risks are increased in those with deep vein throm
|
January 2008
|
|
Bivalirudin for Non-ST-segment Elevation Acute Coronary Syndrome: A Discu
|
May 2007
|
|
Can better INR control be achieved, and if so, how will new anticoagulant
|
March 2007
|
|
Science Advisory Advocates Dual Antiplatelet Therapy with Aspirin and Thi
|
February 2007
|
|
Heart attack and stroke protection of aspirin blocked by Ibuprofen and si
|
September 2006
|
|
Clopidogrel plus aspirin possibly harmful in a broad population with card
|
June 2006
|
|
Homocysteine Lowering Therapy in Vascular Disease - No Reduction in Recur
|
May 2006
|
|
Risk and Benefits of Aspirin in Primary Prevention in Both Men and Women
|
January 2006
|
|
Where can I find an anticoagulation expert near my home or office?
|
October 2005
|
|
Aspirin Resistance: Do we have standardized methods for measurement?
|
September 2005
|
|
Warfarin and Aspirin Combination in Acute Coronary Syndrome
|
August 2005
|
|
Aspirin Discontinuation Perioperatively Increases Cardiovascular Events
|
June 2005
|
|
What is the best loading dose of clopidogrel for patients undergoing perc
|
May 2005
|
|
The Role of Clopidogrel in ST-segment Elevation Acute Coronary Syndrome A
|
May 2005
|
|
Bextra Pulled from Market & Warnings Added to ALL NSAIDs
|
April 2005
|
|
New Data on Aspirin vs. Warfarin in TIA Patients, but Questions Persist
|
March 2005
|
|
News on Vioxx and Congressional Hearings
|
October 2004
|
|
Pulmonary Embolism Following Coronary Artery Bypass Grafting Surgery
|
October 2004
|
|
Exanta not Recommended by FDA Advisory Panel, Causes M.I.s?
|
September 2004
|
|
New Supplement Devoted to Unfractionated Heparin
|
August 2004
|
|
Vioxx (rofecoxib), but not Celebrex (celecoxib), Significantly Increases
|
May 2004
|
|
ClotCare is a 501(c)(3) non-profit organization generously supported by your tax-deductible donations and grants from our industry supporters.
New Postings:
Click here to view full list of new postings
|
ClotCare Home | New Postings | Patient Postings | Clinician Postings | Join Our Email List | Useful Web Links
CE Opportunities | Training Programs | DVT & PE Stories | Editorial Board | Financial Support
About ClotCare | DVT Coalition | Donate to ClotCare | Contact Us
|
|
Key topics discussed on ClotCare include: Blood Clots | Deep Vein Thrombosis (DVT) | Pulmonary Embolism (PE) | Atrial Fibrillation (A. Fib or AF) | Heart Attack | Stroke | Transient Ischemic Attack (TIA) | Mini Stroke | Bleeding Complications | Vascular Surgery | Surgical Blood Clot Removal | Warfarin | Coumadin | Lovenox | Low Molecular Weight Heparin (LMWH) | Heparin | Anticoagulants | Plavix | Aspirin | Antiplatelets | Blood Thinners
|
Copyright 2000-2018 by ClotCare. All rights reserved.
Terms, Conditions, & Privacy | Image Copyright Information
19260 Stone Oak Parkway, Suite 101 | San Antonio, TX 78258 | 210-860-0487
Send comments to webmaster@clotcare.org.
Saturday, November 23, 2024
|